High sodium intake is associated with increased disease activity in multiple sclerosis, according to research published online Aug. 28 in the Journal of Neurology, Neurosurgery & Psychiatry.
There is no link between vitamin D levels in infancy to adult-onset multiple sclerosis, according to research conducted by the Karolinska Institutet in Sweden.
An investigational drug that researchers hope will reverse nerve damage in patients with multiple sclerosis (MS) has been found to be safe and well tolerated in early trials.
The big question is whether it will work, researchers said.
A new monoclonal antibody treatment for multiple sclerosis is safe, according to a phase I trial published online Aug. 27 in Neurology: Neuroimmunology & Neuroinflammation.
Training with a video game balance board results in changes shown in brain magnetic resonance imaging as well as clinical improvement in balance in patients with multiple sclerosis, according to research published online Aug. 26 in Radiology.
The cannabis-based multiple sclerosis drug Sativex has been recommended for use in Wales, making it the first in the United Kingdom to do so. The drug awaits final approval from the government.